Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E0WQ
|
|||
| Former ID |
DAP001350
|
|||
| Drug Name |
Barbital
|
|||
| Synonyms |
Barbitale; Barbitalum; Barbitone; Barbitonum; DEBA; Diemal; Diemalum; Diethylbarbitone; Diethylmalonylurea; Dormileno; Dormonal; Ethylbarbital; Hypnogene; Malonal; Medinal; Sedeval; Uronal; Veroletten; Verolettin; Veronal; Vesperal; Barbital Faes Brand; Barbitale [DCIT]; Diethylbarbituric acid; Faes Brand of Barbital; Barbital (TN); Barbital (VAN); Barbital [INN:JAN]; Barbitalum [INN-Latin]; Veronal (TN); Barbital (JP15/INN); Kyselina 5,5-diethylbarbiturova; Kyselina 5,5-diethylbarbiturova [Czech]; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-(9CI); 5,5-Diethyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5,5-Diethylbarbituric acid; 5,5-diethyl-1,3-diazinane-2,4,6-trione; 5,5-diethylpyrimidine-2,4,6(1H,3H,5H)-trione; 7979P
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Insomnia [ICD-11: 7A00-7A0Z] | Approved | [1] | |
| Therapeutic Class |
Hypnotics and Sedatives
|
|||
| Company |
Schering-Plough
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H12N2O3
|
|||
| Canonical SMILES |
CCC1(C(=O)NC(=O)NC1=O)CC
|
|||
| InChI |
1S/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13)
|
|||
| InChIKey |
FTOAOBMCPZCFFF-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 57-44-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
90340, 589068, 841531, 5611996, 5972305, 7848803, 8151540, 10527896, 11533956, 15219736, 24859202, 24891513, 29215357, 29215358, 29221466, 46508979, 47365376, 48334676, 48415603, 49874104, 50176612, 56459416, 57321239, 57648640, 58694180, 103165760, 104300174, 118189912, 124892181, 125332012, 125736552, 126677738, 127897641, 134338564, 134970868, 137003152, 137204186, 139051997, 144076045, 144205203, 152042447, 160964740, 163120017, 164836116, 164836117, 165319864, 170465829, 175265443, 175442207, 175611463
|
|||
| ChEBI ID |
CHEBI:31252
|
|||
| SuperDrug ATC ID |
N05CA04
|
|||
| SuperDrug CAS ID |
cas=000057443
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | GABA(A) receptor alpha-1 (GABRA1) | Target Info | Antagonist | [1], [2] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Retrograde endocannabinoid signaling | ||||
| GABAergic synapse | ||||
| Morphine addiction | ||||
| Nicotine addiction | ||||
| Reactome | Ligand-gated ion channel transport | |||
| GABA A receptor activation | ||||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | ||||
| Iron uptake and transport | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. | |||
| REF 2 | Effect of barbiturates on polyphosphoinositide biosynthesis and protein kinase C activity in synaptosomes. Neuropharmacology. 1989 Dec;28(12):1317-23. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.